Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002318246 | SCV000851537 | likely benign | Inborn genetic diseases | 2017-02-08 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV002060949 | SCV002485481 | likely benign | Congenital muscular hypertrophy-cerebral syndrome | 2022-01-13 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002485814 | SCV002804129 | likely benign | Congenital muscular hypertrophy-cerebral syndrome; Developmental and epileptic encephalopathy, 85, with or without midline brain defects | 2022-03-28 | criteria provided, single submitter | clinical testing |